BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 16797006)

  • 1. Rat Model of Type 2 Diabetes Mellitus Recapitulates Human Disease in the Anterior Segment of the Eye.
    Wang CL; Skeie JM; Allamargot C; Goldstein AS; Nishimura DY; Huffman JM; Aldrich BT; Schmidt GA; Teixeira LBC; Kuehn MH; Yorek M; Greiner MA
    Am J Pathol; 2024 Jun; 194(6):1090-1105. PubMed ID: 38403162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous Flow Measured by Fluorophotometry in the Mouse.
    Toris CB; Fan S; Johnson TV; Camras LJ; Hays CL; Liu H; Ishimoto BM
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3844-52. PubMed ID: 27447085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allometry and Scaling of the Intraocular Pressure and Aqueous Humour Flow Rate in Vertebrate Eyes.
    Zouache MA; Eames I; Samsudin A
    PLoS One; 2016; 11(3):e0151490. PubMed ID: 26990431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
    Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy: galactose-fed rat model.
    Robison WG
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):4A, 1743-4. PubMed ID: 7635650
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
    Engerman RL; Kern TS
    Arch Ophthalmol; 1995 Mar; 113(3):355-8. PubMed ID: 7887850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
    Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous flow in galactose-fed dogs.
    Toris CB; Lane JT; Akagi Y; Blessing KA; Kador PF
    Exp Eye Res; 2006 Oct; 83(4):865-70. PubMed ID: 16797006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular changes in diabetes mellitus (without diabetic retinopathy)].
    Davidescu FL
    Oftalmologia; 2004; 48(4):13-7. PubMed ID: 15782757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible new concepts relating prostaglandins to various ocular functions.
    Waitzman MB
    Surv Ophthalmol; 1970 Jan; 14(4):301-26. PubMed ID: 4984791
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinopathy in animal models of diabetes.
    Engerman RL; Kern TS
    Diabetes Metab Rev; 1995 Jul; 11(2):109-20. PubMed ID: 7555563
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.